Vladimir  Kostyuk

Dr. Vladimir Kostyuk

orcid

Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 1989 in Biochemical Pharmacology
Verified
Journal Article
Closed access
IAIgor B. Afanas'Ev
Igor B. Afanas'Ev
ADAnatolii I. Dcrozhko
Anatolii I. Dcrozhko
ABAleksander V. Brodskii
Aleksander V. Brodskii
VKVladimir Kostyuk
Vladimir Kostyuk
APAlla I. Potapovitch
Alla I. Potapovitch

1 September 2011 in Mini-Reviews in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
LKL. Korkina
L. Korkina
VKVladimir Kostyuk
Vladimir Kostyuk
CLC. De Luca
C. De Luca
SPS. Pastore
S. Pastore
Plant-derived phenylpropanoids (PPPs) compose the largest group of secondary metabolites produced by higher plants, mainly, for the protection against biotic or abiotic stresses such as infections, wounding, UV irradiation, exposure to ozone, pollutants, and herbivores. PPPs are parent molecules for biosynthesis of numerous structurally and functionally diverse plant polyphenols (simple phenolic acids and esters, glycosylated derivatives of primary PPPs, flavonoids, isoflavonoids, stilbenes, coumarins, curcuminoids, lignans, etc.), which play multiple essential roles in plant physiology. During the last few decades, extensive research has been dedicated to natural and biotechnologically produced PPPs for medicinal use as antioxidants, UV screens, anticancer, antiviral, anti-inflammatory, wound healing, and antibacterial agents. In the present review, the metabolic pathways of phenylpropanoid biosynthesis in plants and their re-construction in biotechnologically engineered systems are described. Chemical physical peculiarities of PPPs defining their antioxidant, metal chelating, and UV-protecting effects as a molecular basis for their anti-inflammatory properties are discussed as well. We focused also on the discovery of PPPs-based anti-inflammatory agents since distinct PPPs were found to modulate molecular pathways underlying inflammatory responses in human cells triggered by different pro-inflammatory stimuli in vitro and to inhibit inflammation in various tissues in vivo. The problem of low bioavailability, fast metabolism, and potential toxicity/sensitization as limiting factors for the development of PPPs-based anti-inflammatory drugs is also highlighted.

1 August 2004 in Archives of Biochemistry and Biophysics
Verified
Journal Article
Closed access
VKV.A. Kostyuk
V.A. Kostyuk
APA.I. Potapovich
A.I. Potapovich
ESE.N. Strigunova
E.N. Strigunova
VKVladimir Kostyuk
Vladimir Kostyuk
IAI.B. Afanas'EV
I.B. Afanas'EV

1 September 2011 in Toxicology and Applied Pharmacology
Verified
Journal Article
Closed access
APAlla I. Potapovich
Alla I. Potapovich
DLDaniela Lulli
Daniela Lulli
PFPaolo Fidanza
Paolo Fidanza
VKVladimir Kostyuk
Vladimir Kostyuk
CLChiara De Luca
Chiara De Luca
LKLiudmila G. Korkina
Liudmila G. Korkina

1 May 2003 in Biochemistry (Moscow)
Verified
Journal Article
Closed access
PDF file
APA. I. Potapovich
A. I. Potapovich
VKVladimir Kostyuk
Vladimir Kostyuk

15 February 2012 in Antioxidants & Redox Signaling
Verified
Journal Article
Closed access
SPSaveria Pastore
Saveria Pastore
DLDaniela Lulli
Daniela Lulli
PFPaolo Fidanza
Paolo Fidanza
APAlla I. Potapovich
Alla I. Potapovich
VKVladimir Kostyuk
Vladimir Kostyuk
LKLiudmila G. Korkina
Liudmila G. Korkina
Aims: To evaluate mechanisms underlying modulation of inflammatory chemokines in primary human keratinocytes (normal human epidermal keratinocytes) and repair-related processes in wound models by plant polyphenols (PPs) with antioxidant and superoxide scavenging properties (verbascoside [Vb], resveratrol [Rv], polydatin [Pd], quercetin [Qr], and rutin). Results: Epidermal growth factor receptor (EGFR)-controlled chemokines CXCL8/interleukin 8 (IL-8), CCL2/monocyte chemotactic protein-1 (MCP-1), and CXCL10/interferon gamma-produced protein of 10 kDa (IP-10) were modulated by transforming growth factor alpha (TGF-α) and by the tumor necrosis factor alpha/interferon gamma combination (T/I). EGFR phosphorylation, nuclear translocation, and downstream cytoplasmic signaling pathways (extracellular regulation kinase [ERK]1/2, p38, STAT3, and PI-3K) were studied. All PPs did not affect TGF-α-induced STAT3 phosphorylation, whereas they suppressed T/I-activated NFkappaB and constitutive and T/I-induced but not TGF-α-induced ERK1/2 phosphorylation. Vb and Qr suppressed total EGFR phosphorylation, but they synergized with TGF-α to enhance nuclear accumulation of phosphorylated EGFR. Vb strongly inhibited TGF-α-induced p38 phosphorylation and T/I-induced NFkappaB and activator protein-1 (AP-1) binding to DNA. Vb was an effective inhibitor of T/I-stimulated chemokine synthesis, and it accelerated scratch wound healing in vitro. Anti-inflammatory and wound healing activities of Vb were confirmed in vivo in the full-thickness excision wound. Although Pd and Rv did not affect EGFR activation/translocation, they and Qr synergized with TGF-α and T/I in the induction of IL-8 transcription/synthesis while opposing enhanced MCP-1 and IP-10 transcription/synthesis connected with pharmacologically impaired EGFR functioning. Innovation: PPs perturb the EGFR system in human keratinocytes, and this effect may be implicated in the regulation of inflammatory and repair-related processes in the skin. Conclusion: Anti-inflammatory and wound healing effects of PPs depend on their interaction with EGFR-controlled cytoplasmic and nuclear pathways rather than on their direct redox properties. Antioxid. Redox Signal. 16, 314–328.